Electronic Cigarettes clinical trials at University of California Health

7 in progress, 6 open to eligible people

Showing trials for

  • Acute Effects of TCIG vs ECIG in PLWH

    open to eligible people ages 21-45

    Randomized controlled trial of acute use of electronic cigarette or tobacco cigarette on parameters of ventricular repolarization and inflammation/oxidative stress.

    at UCLA

  • Cigarette Harm Reduction With Electronic Cigarette Use

    open to eligible people ages 21-70

    This is an observational, crossover study that will be examine use behaviors, chemical exposures, and biological effects of SREC compared to TC use in subjects confined to a research ward setting.

    at UCSF

  • E-cigarettes and Blood Vessel Function

    open to eligible people ages 21-45

    Randomized controlled trial of electronic cigarettes with nicotine, without nicotine, and sham control, on endothelial function and markers of oxidative stress.

    at UCLA

  • E-cigarettes, Nicotine Inhaler, and Blood Vessel Function

    open to eligible people ages 21-45

    Randomized controlled trial of electronic cigarettes with nicotine, without nicotine, nicotine inhaler, and sham-control on endothelial function, oxidative stress and sympathetic nerve activity

    at UCLA

  • ECigs, Inflammation and Oxidative Stress

    open to eligible people ages 21-45

    Randomized controlled trial of acute use of electronic cigarette effect on oxidative stress and inflammation.

    at UCLA

  • Short-Term Cardiovascular Effects of E-Cigarettes: Influence of E-Liquid pH

    open to eligible people ages 21-70

    This study will examine the short-term cardiovascular (CV) effects of e-liquid pH in a randomized, crossover clinical and behavioral pharmacology study of experienced adult e-cigarette users (N=21). The specific aim of the study is to assess the impact of changes in e-liquid pH on nicotine pharmacokinetics, cardiovascular, and subjective effects of e-cigarettes.

    at UCSF

  • Arterial Inflammation and E-Cigarettes

    Sorry, in progress, not accepting new patients

    Arterial inflammation will be compared using PET scanning in 3 groups: 1) Non-smokers, 2) Tobacco cigarette smokers, 3) Electronic cigarette users.

    at UCLA

Our lead scientists for Electronic Cigarettes research studies include .

Last updated: